(NYSE: NGVT) Ingevity's forecast annual revenue growth rate of 2.38% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 7.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 57.1%.
Ingevity's revenue in 2026 is $1,281,000,000.On average, 6 Wall Street analysts forecast NGVT's revenue for 2026 to be $46,897,097,728, with the lowest NGVT revenue forecast at $42,293,701,632, and the highest NGVT revenue forecast at $50,745,249,152. On average, 6 Wall Street analysts forecast NGVT's revenue for 2027 to be $49,270,723,840, with the lowest NGVT revenue forecast at $44,091,903,232, and the highest NGVT revenue forecast at $54,053,940,096.
In 2028, NGVT is forecast to generate $48,191,802,880 in revenue, with the lowest revenue forecast at $46,321,673,216 and the highest revenue forecast at $49,630,364,160.